Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Edwards Lifesciences Corp shares valued at $185,196 were sold by Lippis Daniel J. on Dec 16 ’24. At $74.08 per share, Lippis Daniel J. sold 2,500 shares. The insider’s holdings dropped to 23,189 shares worth approximately $1.75 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Lippis Daniel J. purchased 2,500 shares, netting a total of over 185,196 in proceeds.
Before that, Ullem Scott B. had sold 11,250 shares from its account. In a trade valued at $806,406, the CVP, Chief Financial Officer traded Edwards Lifesciences Corp shares for $71.68 each. Upon closing the transaction, the insider’s holdings decreased to 11,250 shares, worth approximately $2.3 million.
As published in a research note from BofA Securities on December 16, 2024, Edwards Lifesciences Corp [EW] has been rated up from a Neutral to a Buy. As of September 18, 2024, Jefferies has decreased its “Buy” rating to a “Hold” for EW. Earlier on July 31, 2024, Daiwa Securities upgraded its rating. Their new recommendation was “an Outperform” for EW stock which previously was a “a Neutral”.
Analyzing EW Stock Performance
During the last five days, there has been a surge of approximately 1.70%. Over the course of the year, Edwards Lifesciences Corp shares have dropped approximately -1.14%. Shares of the company reached a 52-week high of $96.12 on 03/28/24 and a 52-week low of $58.93 on 07/25/24. A 50-day SMA is recorded $70.23, while a 200-day SMA reached $78.12. Nevertheless, trading volume fell to 1.69 million shares from 4.23 million shares the previous day.
Support And Resistance Levels for Edwards Lifesciences Corp (EW)
According to the 24-hour chart, there is a support level at 74.75, which, if violated, would cause prices to drop to 74.11. In the upper region, resistance lies at 75.70. The next price resistance is at 76.01. RSI (Relative Strength Index) is 64.28 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 1.49, which suggests the price will increase in the coming days. Percent R is at 0.00%, indicating bullish price movement. Stochastics %K at selling indicates that the stock is to be held.
